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Abstract 
Introduction: This study evaluates the potential impact of the publication of conflicting prostate 
cancer (PCa) screening trial results in 2009 and changes to the US Preventive Services Task 
Force (USPSTF) guidelines to recommend against screening in 2012 on temporal trends in PSA 
testing at two participating sites in the NCI-funded Cancer Research Network. 
Methods: Study participants were men aged 40-80 without a history of PCa who sought care at 
Fallon Health (Worcester, MA) or Henry Ford Health System (Detroit, MI) between 2000-2014. 
We used health claims and electronic health record data to identify men who underwent PSA 
testing per calendar year. We also examined trends in PSA testing among high-risk men 
(African-American, family history of PCa). Testing rates were compared between 2000-2008, 
2009-2012, and 2013-2014. 
Results: From a population of 279,350 eligible men, 133,038 (48%) had at least one PSA test 
during the study period. Mean age at PSA test was 57 years, which increased over time at both 
sites. Overall, PSA testing rates rose between 2000-2008 (27-32% of eligible men per year), but 
declined between 2009-2012 (25% of eligible men). Testing rates declined further in 2013-2014 
(23% of eligible men). We observed similar rates of decline in testing for men aged 55-69 and 
those aged ≥70. High-risk men were less likely to be screened across all time periods, although 
data was limited. 
Conclusions: This analysis of two population-based electronic health datasets provides 
evidence of a recent decrease in PSA testing, following an increase in the early 2000s. Although 
we are unable to determine causality, it is plausible that results of recent screening trials and/or 
changes to the USPSTF guidelines have impacted PSA testing practices over the past 14 
years.  
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